Trials / Unknown
UnknownNCT02998827
Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The effectiveness of thalidomide in treating inflammatory bowel disease has been widely recognized. Meanwhile, many serious adverse drug reactions were notified， but no reports on ovarian reserve function.Therefore, this study was to investigate the influence of thalidomide on function of ovarian reserve.
Detailed description
It will be divided two groups of patients according to the treatment itself . One group was treated by thalidomide, the other was other treatment excluding. It will detect the function of ovarian reserve before and after treatment in both two groups, to investigate the influence of thalidomide on function of ovarian reserve.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thalidomide | |
| DRUG | infliximab, azathioprine | other treatment include infliximab, azathioprine |
| OTHER | enteral nutrition |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-11-01
- First posted
- 2016-12-20
- Last updated
- 2016-12-20
Source: ClinicalTrials.gov record NCT02998827. Inclusion in this directory is not an endorsement.